President Donald Trump cut deals with the drugmakers Eli Lilly and Novo Nordisk to increase access to obesity drugs such as Ozempic.
Follow US
Find US on Social Medias
Popular News
Global Coronavirus Cases
Confirmed
0
Death
0
Search